Facial reconstruction

Search LJMU Research Online

Browse Repository | Browse E-Theses

Lessons Learned from Read-Across Case Studies for Repeated-Dose Toxicity

Schultz, TW and Cronin, MTD (2017) Lessons Learned from Read-Across Case Studies for Repeated-Dose Toxicity. Regulatory Toxicology and Pharmacology, 88. pp. 185-191. ISSN 0273-2300

Lessons Learned from Read-Across Case Studies for Repeated-Dose Toxicity.pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (371kB) | Preview


A series of case studies designed to further acceptance of read-across predictions, especially for chronic health-related endpoints, have been evaluated with regard to the knowledge and insight they provide. A common aim of these case studies was to examine sources of uncertainty associated with read-across. While uncertainty is related to the quality and quantity of the read across endpoint data, uncertainty also includes a variety of other factors, the foremost of which is uncertainty associated with the justification of similarity and quantity and quality of data for the source chemical(s). This investigation has demonstrated that the assessment of uncertainty associated with a similarity justification includes consideration of the information supporting the scientific arguments and the data associated with the chemical, toxicokinetic and toxicodynamic similarity. Similarity in chemistry is often not enough to justify fully a read-across prediction, thus, for chronic health endpoints, toxicokinetic and/or toxicodynamic similarity is essential. Data from New Approach Methodology(ies) including high throughput screening, in vitro and in chemico assay and in silico tools, may provide critical information needed to strengthen the toxicodynamic similarity rationale. In addition, it was shown that toxicokinetic (i.e., ADME) similarity, especially metabolism, is often the driver of the overall uncertainty.

Item Type: Article
Uncontrolled Keywords: 1115 Pharmacology And Pharmaceutical Sciences
Subjects: R Medicine > RM Therapeutics. Pharmacology
Divisions: Pharmacy & Biomolecular Sciences
Publisher: Elsevier
Date Deposited: 23 Jun 2017 10:59
Last Modified: 04 Sep 2021 11:24
URI: https://researchonline.ljmu.ac.uk/id/eprint/6732
View Item View Item